Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Clinical trial NCT02146378 · COMPLETED

Trial details

NCT number: NCT02146378
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Transthyretin Familial Amyloid Polyneuropathy

Start date: 2014-01-10
Primary completion: 2023-03-10
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.